Kaelis. Write the bin

Bin cards are readings, not a fill and not a prescription. Open the bin disclaimer

Clip · Clip ยท CNS

LYRICA stops in diabetic neuropathy programs

3 min read · Reviewed

Medically reviewed by Dr. Priya Natarajan, MD - Clinical pharmacology, Dublin

Pregabalin capsules laid out in a week-by-week increase

01Diabetic neuropathy programs

Pooled controlled trials in neuropathic pain from diabetic peripheral neuropathy enrolled 979 people on LYRICA and 459 people on placebo. Premature discontinuation because of adverse reactions was 9% on LYRICA and 4% on placebo. In the LYRICA group, dizziness accounted for 3% of those stops and somnolence for 2%. Fewer than 1% of people on placebo stopped for dizziness or somnolence.

Before you start, stop, or change any medicine, speak with your prescriber or pharmacist. They hold your chart. This bin card does not. Open the bin disclaimer.

Sources

  1. FDA / Pfizer Lyrica (pregabalin) prescribing information

Checked against the current label and reviewed by Dr. Priya Natarajan. See Pick → Check → Tag → Bin.